Teva Pharmaceutical Industries Limited
TEVA
$16.33
-$0.13-0.79%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -2.38% | 4.03% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.38% | 4.03% | |||
| Cost of Revenue | -3.39% | 2.01% | |||
| Gross Profit | -1.35% | 6.18% | |||
| SG&A Expenses | 3.03% | -1.60% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 247.37% | -1,800.00% | |||
| Total Operating Expenses | 0.24% | -0.57% | |||
| Operating Income | -11.06% | 22.89% | |||
| Income Before Tax | 23.05% | -31.02% | |||
| Income Tax Expenses | -59.42% | -89.05% | |||
| Earnings from Continuing Operations | 29.49% | 55.43% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 223.40% | -262.07% | |||
| Net Income | 50.34% | 48.35% | |||
| EBIT | -11.06% | 22.89% | |||
| EBITDA | -8.00% | 17.38% | |||
| EPS Basic | 50.35% | 48.35% | |||
| Normalized Basic EPS | 16.89% | 5.20% | |||
| EPS Diluted | 50.90% | 48.00% | |||
| Normalized Diluted EPS | 16.89% | 5.20% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
